Earnings calls

Sanjiv.Parant. concall ledger

Every earnings call for 531569 — management tone, guidance, KPIs and promise tracking, quarter by quarter.

531569 · 5 transcripts · Healthcare · latest Q3 FY26

Q3 FY26Published 16 Feb 2026Call held 16 Feb 2026

531569 Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹22.1 cr+27% YoYConsolidated EBITDA₹14.1 cr+45% YoYConsolidated EBITDA Margin18.5%Consolidated PAT₹2.38 cr+46% YoY

Consolidated Revenue ₹22 cr (+27% YoY); Consolidated EBITDA ₹14 cr (+45% YoY); Consolidated EBITDA Margin 18.5%. Consolidated Revenue grew 27.1% YoY to INR 22.1 crores.

Read full transcript & analysis

Q2 FY26Published 19 Nov 2025Call held 19 Nov 2025

531569 Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹15.5 cr−14% YoYEBITDA₹2.4 cr−26% YoYEBITDA Margin15.5%PAT₹1.6 cr−28% YoY

Revenue ₹16 cr (−14% YoY); EBITDA ₹2 cr (−26% YoY); EBITDA Margin 15.5%. Revenue for Q2 FY26 stood at INR 15.5 crores, marking a 14.5% decline year-on-year.

Read full transcript & analysis

Q1 FY26Published 12 Aug 2025Call held 12 Aug 2025

531569 Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹17.9 cr+9% YoYEBITDA₹2.7 cr+11% YoYEBITDA Margin15%PAT₹1.7 cr

Revenue ₹18 cr (+9% YoY); EBITDA ₹3 cr (+11% YoY); EBITDA Margin 15.0%. Revenue grew 8.9% YoY to INR17.9 crores.

Read full transcript & analysis

Q4 FY25Published 27 May 2025Call held 27 May 2025

531569 Q4 FY25 Earnings Call Transcript & Analysis

FY25 Revenue₹70.1 cr+29% YoYFY25 EBITDA₹11.6 cr+32% YoYFY25 EBITDA Margin16.5%FY25 PAT₹8.1 cr+31% YoY

FY25 Revenue ₹70 cr (+29% YoY); FY25 EBITDA ₹12 cr (+32% YoY); FY25 EBITDA Margin 16.5%. Q4 FY25 Revenue grew 41.3% YoY to INR 18.2 crores.

Read full transcript & analysis

Q3 FY25Published 11 Feb 2025Call held 11 Feb 2025

531569 Q3 FY25 Earnings Call Transcript & Analysis

Q3 FY25 Revenue₹17.4 cr+16% YoYQ3 FY25 EBITDA₹2.86 cr+29% YoYQ3 FY25 EBITDA Margin16.5%Q3 FY25 PAT₹1.9 cr+16% YoY9M FY25 Revenue₹51.92 cr+25% YoY

Q3 FY25 Revenue ₹17 cr (+16% YoY); Q3 FY25 EBITDA ₹3 cr (+29% YoY); Q3 FY25 EBITDA Margin 16.5%. Q3 FY25 Revenue was INR17.4 crores, a 15.9% YoY growth.

Read full transcript & analysis